ATA3431: Allogeneic CD19/CD20 Bispecific CAR EBV T Cells for the Treatment of B-Cell Malignancies

被引：3
|
作者：
Cha, Seung [1 ]
Charbonneau, Morgan [1 ]
Brito, Alfonso [1 ]
Habibi, Ania [1 ]
Pham, Christina [1 ]
Nguyen, Cokey [1 ]
机构：
[1] Atara Biotherapeut, Thousand Oaks, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-181199
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Bispecific CAR T-cells for B-cell Malignancies
    Furqan, Fateeha
    Shah, Nirav N.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (08) : 1005 - 1015
  • [42] Leukemia Cell Surface Antigen Modulation Induced By Dual CD19/CD20 Chimeric Antigen Receptor (CAR)-T Cells
    Schneider, Dina
    Xiong, Ying
    Wu, Darong
    Nolle, Volker
    Schmitz, Sarah
    Kaiser, Andrew
    Dropulic, Boro
    Orentas, Rimas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S209 - S210
  • [43] TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss
    Li, Guangchao
    Zhang, Qing
    Liu, Zhi
    Shen, Huijuan
    Zhu, Yangmin
    Zhou, Zhao
    Ding, Wen
    Han, Siqi
    Zhou, Jie
    Ou, Ruiming
    Luo, Min
    Liu, Shuang
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [44] TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss
    Guangchao Li
    Qing Zhang
    Zhi Liu
    Huijuan Shen
    Yangmin Zhu
    Zhao Zhou
    Wen Ding
    Siqi Han
    Jie Zhou
    Ruiming Ou
    Min Luo
    Shuang Liu
    Cancer Cell International, 21
  • [45] Preclinical Evaluation of Human Placental-Derived Allogeneic CD19 CAR-T Cells Against B Cell Malignancies
    Karasiewicz, Kathy
    He, Shuyang
    Ng, Mary
    Tess, Kristina
    Ling, Weifang
    Kaufmann, Gunnar F.
    Zeldis, Jerome B.
    Ji, Henry
    Hariri, Robert
    Zhang, Xiaokui
    BLOOD, 2019, 134
  • [46] Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies
    Singh, Harjeet
    Srour, Samer A.
    Milton, Denai R.
    McCarty, Jessica
    Dai, Cuiping
    Gaballa, Mahmoud R.
    Ammari, Mariam
    Olivares, Simon
    Huls, Helen
    De Groot, Eleanor
    Marin, David
    Petropoulos, Demetrios
    Olson, Amanda L.
    Anderlini, Paolo
    Im, Jin S.
    Khouri, Issa
    Hosing, Chitra M.
    Rezvani, Katayoun
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Cooper, Laurence J. N.
    Kebriaei, Partow
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] A CD19/CD20-Directed Bispecific CAR-T Cell Therapy in Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)
    Larson, Sarah M.
    Chen, Yvonne Y.
    Johnston, Jim
    Roy, Sylvain
    Patel, Pinakin
    Benjamin, Jonathan E.
    BLOOD, 2023, 142
  • [48] Tafasitamab Monoclonal antibody targeting CD19 Treatment of B-cell malignancies
    Narkhede, M.
    Cheson, B. D.
    DRUGS OF THE FUTURE, 2020, 45 (09) : 641 - 651
  • [49] Analysis of the CD19 and CD20 antibodies in the B cell section of the workshop.
    Sato, S
    Ono, N
    Tedder, TF
    TISSUE ANTIGENS, 1996, 48 (4-II): : BC301 - BC301
  • [50] Targeting CAR T Resistance Due to CD19 Loss with CD79b-Specific CAR T Cells in B-Cells Malignancies
    Chu, Fuliang
    Weng, Jinsheng
    Kuang, Shao-Qing
    Cheng, Xiaoyun
    Cao, JingJing
    Liu, Jingwei
    Karri, Swathi
    Reddy, Adithi
    Neelapu, Sattva S.
    BLOOD, 2018, 132
12345